Heart Doc VIP with Dr. Joel Kahn cover image

Episode 489: Big Heart Health News You'll Want To Know About

Heart Doc VIP with Dr. Joel Kahn

00:00

Evolocumab Prevents Events in Diabetes

Dr. Kahn discusses JAMA data showing Repatha (evolocumab) reduced first major cardiovascular events in diabetics without prior atherosclerotic events.

Play episode from 20:04
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app